The therapeutic effect of garenoxacin on infectious diseases in otorhinolaryngology

DOI 1 Citations

Bibliographic Information

Other Title
  • メシル酸ガレノキサシン(ジェニナック(R))の臨床効果

Search this article

Description

We assessed the therapeutic effect of garenoxacin (GRNX) on various infectious diseases in the ear, nose and throat. GRNX was administered to a total of 62 patients with an acute infection for several days. The effective rates of GRNX treatment in ear infection, acute parasinusitis, acute infection of the throat and acute tonsillitis was 83.3%, 100%, 87.6% and 100%, respectively. In addition, GRNX treatment which was administered within five days after disease onset was more effective than that administered more than six days after onset (p < 0.05). These results suggest that GRNX therapy during the short term may therefore be very useful for the treatment of acute otorhinolaryngological infectious diseases.

Journal

Citations (1)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top